PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 50: Articles 24501-25000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Nepal Contraceptive Prevalence Survey Report 1981 for Piuthan District.
  2. Nepal, Contraceptive Prevalence Survey Report 1981 for Rukum District.
  3. Neuro-ophthalmological complications of contraceptive pills.
  4. New development in contraceptive technology.
  5. New family planning commission.
  6. A new key to the use of hormonal contraception (author's transl) [Hormonale Antikonzeption: ein weiterer Schlussel zum Gebrauch.]
  7. A new look at contraception.
  8. New problems in family planning work since the implementation of responsibility system in rural areas.
  9. New strategies for the delivery of maternal/child health and family planning services in rural and semi-urban slum areas of Mexico. Contract no. AID/pha-C-1200. Final report.
  10. New strategies for the delivery of maternal/child health and family planning services in rural and semi-urban slum areas of Mexico. Final report.
  11. No association between contraceptive usage and congenital malformations in offspring.
  12. Nodular erythema and oral contraception: evidence of an anti-ethinyl-estradiol antibody. [Erytheme noueux et contraception orale: mise en evidence d'un anticorps anti-ethinyl-estradiol.]
  13. Nonphysicians in family planning and family health in Thailand.
  14. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
  15. A note on measuring the independent impact of family planning programs on fertility declines.
  16. Nursing protocol to improve the effectiveness of the contraceptive diaphragm.
  17. Nutrition, fertility and family planning.
  18. Nutrition, population, and family planning [abstract]
  19. Observations concerning family planning education in China.
  20. Oestrogen containing oral contraceptives decrease prostacyclin production (author's transl) [Les contraceptids oraux a base d'estrogenes reduisent la production de la prostacycline.]
  21. Oestrogen containing oral contraceptives decrease prostacyclin production. [Letter]
  22. Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome.
  23. Oestrogens and contraception.
  24. On oral contraceptive safety: cardiovascular problems [editorial]
  25. On the behavior of serum lipids after short and long-term application of different hormonal contraceptives. [Zum Verhalten der Serumlipide bei Kurz- und Langzeitapplikation verschiedener hormonaler Kontrazeptiva.]
  26. On the influence of hormonal contraceptives to various biochemical parameters of saliva and serum. [Zum Einfluss hormonaler Kontrazeptiva auf verschiedene biochemische Speichel- und Serumparameter.]
  27. On the use of linear programming for family planning resource allocation.
  28. Oncological aspects of hormonal contraception. [Onkologicheskie aspekty gormonal 'noi kontraseptsii.]
  29. One-half of all married women in Turkey practice contraception; only 2 in 10 use efficient methods.
  30. Operational proposals to reinforce the role of the Raida Rifiaa in family planning and rural development: Egypt.
  31. Operations research project experience. the Zaire Family Planning Project.
  32. Operations research project experience: the Zaire Family Planning Project: on planning for data and information system.
  33. Oral and injectable contraceptives: effects on breast milk and child growth in Bangladesh.
  34. Oral contraception and breast pathology (author's transl) [Contraccezione orale e patologia della mammella.]
  35. Oral contraception and cancer risk. [Orale Kontrazeption und Krebsrisiko.]
  36. Oral contraception and cerebrovascular accidents. [Contraception orale et accidents vasculaires cerebraux.]
  37. Oral contraception and circulatory disease [letter]
  38. Oral contraception during lactation: a global survey of physician practice.
  39. Oral contraception: mechanism of action.
  40. Oral contraception: which pill? [La contraception orale: quelle pilule?]
  41. Oral contraceptive exposure of amenorrheic women with and without prolactinomas.
  42. Oral contraceptive hazards: 1981.
  43. Oral contraceptive medication in prevention of psychotic exacerbations associated with phases of the menstrual cycle.
  44. Oral contraceptive steroid plasma concentrations in smokers and non-smokers.
  45. Oral contraceptive therapy, stroke, and pregnancy risk. [Answers to questions]
  46. Oral contraceptive use and early abortion as risk factors for breast cancer in young women.
  47. Oral contraceptive use and prevalence of infection with Chlamydia trachomatis in women.
  48. Oral contraceptive use, sexual activity, and cervical carcinoma.
  49. Oral contraceptives and birth defects.
  50. Oral contraceptives and blood pressure.
  51. Oral contraceptives and breast disease.
  52. Oral contraceptives and cardiovascular disease.
  53. Oral contraceptives and cardiovascular disease. (Second of two parts)
  54. Oral contraceptives and cardiovascular disease. Pt. 1.
  55. Oral contraceptives and circular disease [letter]
  56. Oral contraceptives and circulatory disease [letter]
  57. Oral contraceptives and circulatory disease [reply of the authors] [letter]
  58. Oral contraceptives and depression: impact, prevalence and cause.
  59. Oral contraceptives and hepatic tumors. [Anticonceptionnels oraux et tumeurs hepatiques.]
  60. Oral contraceptives and hepatic vein thrombosis.
  61. Oral contraceptives and liver disease.
  62. Oral contraceptives and liver tumors. [Az oralis fogamzasgatlok es majdaganat.]
  63. Oral contraceptives and myocardial infarction [letter]
  64. Oral contraceptives and myocardial infarction [response to letters]
  65. Oral contraceptives and oral candidiasis. [Orale Kontrazeptiva und Candida-Besiedlung der Mundhoehle.]
  66. Oral contraceptives and periodontal health.
  67. Oral contraceptives and risk of ovarian cancer.
  68. Oral contraceptives and the decline in mortality from circulatory disease.
  69. Oral contraceptives and the risk of myocardial infarction [letter]
  70. Oral contraceptives and the risk of myocardial infarction [letter]
  71. Oral contraceptives.
  72. Oral contraceptives. Vol. 5.
  73. Oral contraceptives: their link to depression and suicide.
  74. Oral contraceptives: what's new?
  75. Oral hormonal contraceptives and benign liver tumors (author's transl) [Kontrazeptiva und gutartige Lebertumoren.]
  76. An organizational and behavioral analysis of the contraceptive compliance process.
  77. Organized efforts correlates of contraceptive usage and continuation in rural Bangladesh.
  78. An overview of studies on estrogens, oral contraceptives and breast cancer.
  79. Overview of the National Population and Family Planning Program in Indonesia.
  80. Ovulation method of contraception. [Letter]
  81. Ovulation method of contraception. [Letter]
  82. Ovulation method of natural family planning.
  83. Pakistan's family planning program.
  84. Panel discussion 1: the future of LHRH analogs as contraceptive agents for men.
  85. Panel discussion 2: further development of LHRH analogs as contraceptive agents for women.
  86. Patentex-oval--an intrauterine contraceptive agent. [Patentex-Oval--antykoncepcyjny srodek dopochwowy.]
  87. Patient profile, national reporting system for family planning services: United States, 1978.
  88. Patterns of awareness and behaviour of Egyptian farmers in relation to family planning.
  89. Patterns of contraceptive use around the world.
  90. Peliosis hepatis, oral contraceptives and hepatic carcinoma: a case treated surgically (author's transl) [Peliosis hepatica, anticonceptivos orales y hepatocarcinoma: paciente tratado quirurgicamente.]
  91. Pelvic actinomycosis associated with intrauterine contraceptive devices.
  92. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
  93. The People's Court of Xinning County held public trial of a case of sabotaging family planning and unpremeditated manslaughter.
  94. A people's movement for health and family planning.
  95. Peptide contraception--new principles for family planning. [Peptid kontraception--nya principer for fodelsekontroll.]
  96. Perceived physician humaneness, patient attitude, and satisfaction with the pill as a contraceptive.
  97. Perception of family planning service availability in rural Malaysia.
  98. A perilous paradox: the contraceptive behavior of college students.
  99. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill.
  100. Personal values affecting decisions to adopt family planning.
  101. A perspective on family planning training programs.
  102. Phase 1 clinical trial of two contraceptive preparations: norethisterone enanthate (NEN) and norethisterone acetate (NET)
  103. A physician's reference to natural family planning: an introduction to the sympto-thermal method.
  104. Physiological method and intrauterine devices for contraception. [O fiziologicheskom metode i vnutrimatochnykh sredstvakh kontratseptsii.]
  105. Physiology and contraceptive effects of LHRH and agonistic analogs in female animals.
  106. The pill ideology: the other side of family planning. [A ideologia da pilula: a outra face do planejamento familiar.]
  107. The place of conventional contraception in the Egyptian family planning program.
  108. The place of family planning in family health services in Egypt.
  109. Place of intrauterine devices in contraception (author's transl) [Place du dispositif intra-uterin en contraception.]
  110. The place of posterior colpotomy as a method of surgical contraception.
  111. The place of surgical contraception in the world today.
  112. Planned parenthood first--IPPF and the problem of abortion.
  113. Planned parenthood: ideas for the 1980s.
  114. Plants used in Haiti for birth control. [Les plantes utilisees en Haiti pour le controle des naissances.]
  115. Plasminogen, fibrinogen, alpha2-antiplasmin and antithrombin-III levels during a single cycle of a combined oral contraceptive regime.
  116. Policy issues in integrated approaches to family planning: an analytical framework.
  117. Political and socio-economic factors and family planning programs in less developed countries: a cross-national analysis.
  118. Polyurethane contraceptive vaginal sponge: product modifications resulting from user experience.
  119. Population and community development: demographic and socio-economic impacts of integrating family planning with community development in new land settlements in Malaysia.
  120. Population and family planning in Thailand 1981.
  121. Population and family planning program: an integral part of total community development in DKI Jakarta.
  122. Population and family planning research, Bangladesh: an annotated bibliography.
  123. Population dynamics and family planning in Dublin, Ireland.
  124. Population policy and compulsion in family planning.
  125. Population policy and family planning communication strategies in the Arab states region. Vol. 1: summaries of pertinent literature and research studies.
  126. Population/family planning thesaurus: 1981 supplement.
  127. Porphyria cutanea tarda in female patients with special regard to hormonal contraception (author's transl) [Porphyria cutanea tarda bei Frauen unter besonderer Berucksichtigung der hormonellen Kontrazeption.]
  128. Portal vein thrombosis and fatal pulmonary thromboembolism associated with oral contraceptive treatment.
  129. Possible association of angiosarcoma with oral contraceptive agents.
  130. Post-partum development of a mesenteric venous infarct and portal thrombosis in a young woman taking an oral contraceptive (author's transl) [Infarctus mesenterique veineux avec thrombose portale chez une jeune fille en post-partum et sous contraceptifs oraux.]
  131. Postabortal contraception.
  132. Postcoital contraception letter.
  133. Postcoital contraception with 0.75 mg d-norgestrel (Postinor)
  134. Postcoital contraception [letter]
  135. Postcoital contraception.
  136. Postcoital contraception.
  137. Postcoital contraception.
  138. Postcoital contraception. [Postcoitale anticonceptie.]
  139. Postpartum contraception.
  140. Potential impact on birth rates of reforms in laws governing contraceptive marketing.
  141. Precursor stage of hepatocellular neoplasm following long exposure to orally administered contraceptives.
  142. Preferences for number and sex of children and contraceptive use in Korea.
  143. Preferences for number and sex of children and contraceptive use in the Republic of Korea.
  144. Pregnancy associated protein in women using hormonal contraception (author's transl) [Pregnancy zone protein (PZP) u zen uzivajicich hormonalni antikoncepci.]
  145. A preliminary assessment of the potential for a subsidized contraceptive marketing program in rural Thailand.
  146. Preliminary experience with a family planning risk-scoring system.
  147. Preliminary observation of histologic, histochemical and electron microscopic examinations of endometrium after implantation of a contraceptive prosthesis.
  148. A preliminary report of the national survey of fertility, mortality and family planning in Thailand, 1979.
  149. A preliminary report on the relationship between serum antithrombin III concentration in pre- and post-operative patients and in women on oral contraceptives.
  150. Preliminary results of research in a program of CM/BBT supported by the Office of Family Planning, U.S. Department of Health and Human-Services, and the Office of Contraceptive Research, U.S. National Institutes of Health.
  151. Premarital use of family planning: effects on age at marriage.
  152. Presentation of the (Contraceptive Prevalence Survey) by Westinghouse Health Systems. [Presentacion de la EPA por Westinghouse Health Systems.]
  153. Preventive aspects of M.T.P. and implementing family planning devices in overlooked group.
  154. Primary health care and the integrated family planning program.
  155. Primary ovarian pregnancy and the intrauterine contraceptive device.
  156. Pro-forma marketing plan for an urban-based commercial retail sales program in support of the Urban Family Planning Program of the Badan Koordinasi Keluarga Berencana Nasional (BKKBN)
  157. The problem of inflammatory diseases of the adnexa in intrauterine contraception. [Zur Problematik der entzundlichen Adnexerkrankungen bei intrauteriner Kontrazeption.]
  158. Problems in adolescent contraception. [Probleme bei der Kontrazeption Jugendlicher.]
  159. Problems of contraception in sexually active female adolescents. Results of an empirical study. [Probleme der Kontrazeption bei weiblichen, sexuell aktiven Jugendlichen. Ergebnisse einer empirischen Untersuchung.]
  160. Problems of measurement of family planning variables from survey and services statistics.
  161. Proceedings of the Second Bi-Annual Seminar on Family Planning Operations Research.
  162. Procreation--in the light of the Halacha: family planning and birth control. 2nd ed.
  163. A profile of college students' information sources, knowledge and attitudes on reproduction and contraception in Cebu, Central Philippines.
  164. Progestagenic contraception or contraception through pure progestagens. [La contraception progestative ou par progestatifs purs.]
  165. Progress report on a multi-service family planning mobile unit September, 1981.
  166. Prolonged pregnancy after oral contraceptive therapy.
  167. Prolonged use of medroxyprogesterone acetate for contraception. [Uso prolongado del acetato de medroxiprogesterona en la anticoncepcion.]
  168. Promising progress has been made in the study of male contraception by physical means in our country.
  169. The promotion of birth control by the United States Agency for International Development.
  170. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
  171. A prospective multicentre trial of the ovulation method of natural family planning. Pt. 1. The teaching phase.
  172. A prospective multicentre trial of the ovulation method of natural family planning. Pt. 2. The effectiveness phase.
  173. Prostaglandin synthetase inhibitors in the treatment of secondary dysmenorrhoea associated with intra-uterine contraceptive device or endometriosis.
  174. Prostaglandins in primary dysmenorrhea: comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives.
  175. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease.
  176. The provision and use of contraceptive services in three study areas: summary of findings.
  177. Pseudo-sulfur granules associated with intrauterine contraceptive devices.
  178. Psychiatric complications of progesterone and oral contraceptives.
  179. Psychic disturbances in women during oral contraception (author's transl) [Psychische Storungen bei hormonaler Kontrazeption der Frau.]
  180. Psychological aspects in contraceptive counseling. [Psykologiska synpunkter paa preventivmedelsraadgivning.]
  181. Psychological aspects of contraception with Multiload Cu250. [Psychologische Aspekte der Kontrazeption mit dem Multiload Cu250.]
  182. Psychological viewpoints in counseling on contraceptives. [Psykologiska synpunkter pa preventivmedelsradgivning.]
  183. Psychosis associated with oral contraceptive-induced chorea.
  184. Psychosocial maturity and teenage contraceptive use: an investigation of decision-making and communication skills.
  185. Psychosociological approach to intrauterine contraception (author's transl) [Approche psychosociologique de la contraception uterine.]
  186. Qinghai official urges planned parenthood.
  187. Quantitative analysis of some decision rules for family planning in an oriental society.
  188. Quantitative effect of family planning programme in India (1965-76)
  189. Questionnaires for the Contraceptive Prevalence Surveys in Paraguay (1977); Guatemala, El Salvador, and Sao Paulo State, Brazil (1978); and Jamaica, Panama, and Piaui State, Brazil (1979)
  190. The R.C.G.P. Oral Contraception Study. [Reply to letter of Grant and Robinson] [Letter]
  191. A randomized prospective study of the use-effectiveness of two methods of natural family planning.
  192. Rare complication of intrauterine contraception. [Redkoe oslozhnenie intrakorporal'noi kontraseptsii.]
  193. Recent advances in contraception.

     

  194. Recurrent hemolytic uremic syndrome during oral contraception.
  195. Reducing the risk of oral contraceptive-induced thrombosis.
  196. Regional aspects of family planning and fertility behavior in Indonesia.
  197. Regional hemodynamics in intrauterine contraception in the early puerperium. [Regionarhaia gemodinamika u rodil'nits pri vnutrimatochnoi Kontratseptsii v rannie sroki posle rodov.]
  198. Regional Seminar on Evaluation of Schemes and Strategies for Integrated Family Planning Programmes with Special Reference to Increased Involvement of Local Institutions.
  199. Regional trends in psycho-social research in fertility and family planning.
  200. Regulations concerning the promotion of family planning of the Shanghai Municipal Revolutionary Committee.
  201. Relationship between women's attitudes and choice of birth control.
  202. Relative status of women and family planning.
  203. Relocation and population planning: a study of the implications of public housing and family planning in Singapore.
  204. Removal of interference in the differential pulse polarographic determination of progestogens in some combined low-dosage oral contraceptives.
  205. Renmin Ribao editorial urges planned parenthood.
  206. Reply to Shapiro, Sloane and Rosenberg's letter concerning thrombosis and oral contraceptives] [Letter.
  207. Report of the Committee for the Study of Contraceptive Requirements of Sri Lanka for the period 1981-1984.
  208. Report of the International Workshop on Training of Trainers in Family Life Education Relative to Family Planning, held at the Faculty of Public Health, Mahidol University, September 21 - October 2, 1981, Bangkok, Thailand.
  209. A report on activities to strengthen the financial management of the family planning and integrated community health projects of Nepal.
  210. A report on assistance to develop a national maternal and child health and family planning program in Rwanda.
  211. A report on assistance to develop family planning materials for the national day care program of Jamaica.
  212. A report on Bangladesh Family Planning Programme as compared with that of China.
  213. A report on current activities of the Population Council: studies in contraceptive development, publications, and research.
  214. Report on population and family planning activities.
  215. A report on selected family planning and population service programs in Egypt.
  216. Report on study of minors who came to the Planned Parenthood Clinic for the first time.
  217. A report on the Egyptian State Information Service's mass media campaign to support population and family planning.
  218. Report on the project to provide primary health care and family planning in the Mid-South, Peru, Health Region.
  219. Report on the survey on "The attitudes and levels of awareness of human rights in general and women's rights in particular and its relation to family planning practices".
  220. Reproductive processes and contraception.
  221. Research activity on systemic contraceptive drugs by the U. S. pharmaceutical industry, 1963-1976.
  222. Research at UF and in London paves way for more reliable natural family planning [press release]
  223. Research needs in family planning.
  224. Research on maternal-child health and family planning 1980, state of Paraiba. [Pesquisa sobre saude materno-infantil e planejamento familiar 1980, Estado da Paraiba.]
  225. Research on maternal-child health and family planning, 1980, Rio Grande do Norte. [Pesquisa sobre saude materno-infantil e planejamento familiar, 1980, Rio Grande do Norte.]
  226. Research on maternal-child health and family planning, 1980, State of Bahia. [Pesquisa sobre saude materno-infantil e planejamento familiar, 1980 Estado de Bahia.]
  227. Resistance to contraception. [Resistance a la contraception.]
  228. Response of unmarried adolescents to contraceptive advice and service in Nigeria.
  229. Results of using intrauterine contraceptives immediately after induced abortion. [Rezul'taty primeneniya vnutrimatochnoi kontratseptsii neposredstvenno posle operatsii iskusstvennogo aborta.]
  230. Retinal disturbance with phenothiazine derivatives and oral contraceptives (author's transl)
  231. Reversal of long-standing renal insufficiency by Captopril in a patient with relapsing hemolytic uremic syndrome due to an oral contraception.
  232. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
  233. A review of the Family Planning Social Marketing Project Bangladesh.
  234. RIA of insulin in the determination of aberrations in the glycide metabolism in women using steroidal contraceptive preparations. [RIA des insulins zur feststellung von abweichungen im glycidstoffwechsel bei frauen unter anwendung steroider kontrazeptionspraparate.]
  235. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives.
  236. Risk-taking and contraceptive behavior among unmarried college students.
  237. Risks and follow-up of women taking combination oral contraceptives. [Risques et surveillance des femmes traitees aux oestro-progestatifs.]
  238. Risks and perspectives of steroid contraceptives. [Rizika a perspektivy steroidni kontracepce.]
  239. Role of copper ions in contraception. [Rola jonow miedzi w zapobieganiu ciazy.]
  240. The role of decentralized family planning in response to the population changes caused by modernization in Iran.
  241. The role of family planning communications--an agent of reinforcement or change.
  242. The role of family planning in national development.
  243. The role of family planning programs in fertility declines in less developed countries, 1958-1977.
  244. The role of local institutions in integrated family planning programmes: steps towards community participation.
  245. The role of long-acting injectable contraceptives in family planning.
  246. The role of national conferences and training as a strategy to expand the integrated family planning-nutrition-parasite control project.
  247. Role of ultrasonography in a family planning center.
  248. The role of women's groups in promoting family planning in Indonesia.
  249. Rubella immunity in family planning clinic attenders.
  250. Rural home delivery of contraceptives in Colombia.
  251. The safety of vaginal contraception.
  252. Schirmer-I test, oral contraceptives and pregnancy (author's transl) [Schirmer-I Test, orale Kontrazeptiva und Schwangerschaft.]
  253. Selected bibliography of research on contraception: orthodox, western-based and ethnic Malaysian methods.
  254. Selected characteristics of exposed women wanting no more children and not using contraceptives.
  255. Selected tables on family size and family planning from the Canberra Population Survey, 1978 [tables]
  256. The self and contraceptive behavior.
  257. Self-care/health maintenance and contraceptive use, information needs, and knowledge of a selected group of university women.
  258. Self-reliance of family planning associations.
  259. The sensibility of the hypophysis, the gonads and the thyroid of adolescents before and after the administration of oral contraceptives: a resume.
  260. Sequence of events following adoption of contraception: an exploratory analysis of 1973 fertility history data.
  261. Sex and birth control: a guide for the young. Rev. ed.
  262. Sex differentials in attitude to family size in Nigeria and their implications for family planning programmes.
  263. Sex education and family planning.
  264. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
  265. Sex, contraception and motherhood in Jamaica.
  266. Sexual attitude-behaviour inconsistencies and contraceptive usage. What is the role of sex education in schools?
  267. Sexual behavior and contraception in young unmarried people. [Conducta sexual y anticonceptiva en jovenes solteros.]
  268. Sexual relations, contraception, pregnancy and birth: their premarital incidence in Flanders (author's transl) [Geslachtsverkeer, voorbehoeding, zwangerschap en geboorte voor het huwelijk in Vlaanderen.]
  269. Sexuality and contraception.
  270. Sexuality, fertility and contraception in disability.
  271. Shanghai stipulates a number of planned parenthood regulations.
  272. Shanghai: family planning.
  273. Shifang County: family planning.
  274. Shortage of contraceptives in Peking.
  275. Should the media advertise contraceptives?
  276. Sichuan province strengthens leadership over family planning work.
  277. Side effects of hormonal contraception. [Nebenwirkungen der hormonalen Kontrazeption.]
  278. Side effects of oral contraceptives (author's transl) [Vedlajsie ucinky peroralnych antikonceptiv.]
  279. Sierra Leone Home Economics Association. Summary report on the family planning-population education projects and activities of SLHEA, 1973-1981.
  280. The Singapore National Family Planning and Population Programme, 1966-1980.
  281. The Singapore National Family Planning and Population Programme, 1966-1981.
  282. Size distribution, forms and variations of glandular tissue of the breast. Histometric examination on the question of the effect of contraceptives on the lobular parenchyma. [Uber Grossenordnung, Formen und Varianten der Drusenlappchen der Mamma. Histometrische Untersuchungen zur Frage des Einflusses von Kontrazeptiva auf das lobulare Parenchym.]
  283. Skin changes from taking hormonal contraceptives. [Hautveranderungen unter der Einnahme hormonaler Kontrazeptiva.]
  284. Smoking, oral contraceptives, and serum lipid and lipoprotein levels in youths.
  285. Some psychological correlates of family planning among women.
  286. Some thoughts on Contraceptive Prevalence Surveys.
  287. Some thoughts on the family planning programme.
  288. A South African-made copper intra-uterine contraceptive device: preliminary report.
  289. Spontaneous resolution of oral-contraceptive-associated liver tumor.
  290. State family planning commission established.
  291. Statement on postcoital contraception.
  292. Statement on steroidal oral contraceptives.
  293. The status of surgical contraception in Brazil.
  294. Status report on an evaluation of the demographic impact of a contraceptive distribution project in Matlab Thana, Bangladesh.
  295. Sterilisation and the National Health Service: a report by the Birth Control Trust.
  296. Sterilisation as a part of a family planning service.
  297. Sterilization as part of a family planning service.
  298. Steroidal contraception [editorial]
  299. Steroidal contraception in the 80's: the role of current and new products.
  300. Studies in family planning in Tunisia. [Entwicklung der Familienplanung in Tunesien.]
  301. Studies on estradiol occupied and unoccupied receptors in human endometrial cytosol and nucleus: steroid receptors throughout the menstrual cycle and in cases of oral contraceptives administration (author's transl)
  302. Studies on long-acting oral contraceptives.
  303. Studies on the antifertility effect of gossypol, a new contraceptive for males.
  304. Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors.
  305. Study of 95 (ninety five) cases of injectable contraceptive (Noristerat) acceptors in FPIA Model Family Planning Clinic, Chittagong Medical College Hospital, Chittagong. One year study 18-4-79 to 18-4-80.
  306. A study of the factors affecting discontinuation of women using injectable contraceptives.
  307. A study on motivational factors influencing sterilisation (vasectomy) in a mass family planning camp.
  308. A study to determine the effect of betadine vaginal cleansing kit on cervical flora after insertion of an intra-uterine contraceptive device.
  309. The Subanen of Zamboanga del Sur. Said to be the first tribe to practise birth control.
  310. Subjective assessment and cardiovascular response to ischemic pain in young, healthy women users and non-users of oral contraceptives.
  311. Success in family planning campaigns [letter]
  312. Summary proceedings of the Contraceptive Social Marketing Asia Regional Conference, Dacca, Bangladesh, 20-24 June 1981.
  313. Summary report: focus group interviews on family planning methods and products.
  314. Surgical contraception.
  315. Surgical family planning methods: the role of the private physician.
  316. Survey implications of major methodological issues in family planning programme evaluation.
  317. Survey of family planning services provided to teenagers in five public health projects.
  318. Survey on maternal-child health and family planning, Pernambuco--1980. [Pesquisa sobre saude materno-infantil e planejamento familiar, Pernambuco--1980.]
  319. Surveys indicate most men favor birth control.
  320. Sweden strongly approves Depo-Provera as contraceptive.
  321. Tailoring contraception to patients.
  322. Taiwan's national family planning program.
  323. Talk on Depo Provera, for National Family Planning and Reproductive Association, May 3, 1981.
  324. The teacher and family planning. [El maestro y la planificacion familiar.]
  325. Technical advances in surgical contraception.
  326. Teenage pregnancy and adolescent risk-taking: the influence of alienation, feminist ideology, contraceptive orientation, socioeconomic status, and traditional/fundamentalist religion upon the adolescent woman's decision whether to contracept.
  327. Teenagers who use organized family planning services: United States, 1978.
  328. Teenagers who used organized family planning services: United States, 1978.
  329. Teratogenic hazards of oral contraceptives analyzed in a national malformation register.
  330. Terminology and core curricula in natural family planning (NFP). Report of a Natural Family Physicians Conference, Los Angeles, January 25-26 1981.
  331. Test and teach. 2. Actinomyces israelii in a woman using intrauterine contraceptive device (IUCD)
  332. Tetracycline and oral contraceptives [letter]
  333. Thailand: summary report of the Thai Integrated Family Planning and Parasite Control Program 1976-1980.
  334. Thailand: utilization of TBAs in family planning and maternal and child care.
  335. Theoretical framework for family planning programme evaluation through surveys.
  336. The Third Regional Training Course on the Control of Intestinal Helminthic Infections with Special Emphasis on Soil-transmitted Helminthiasis, Family Planning Practice and their Integrated Program.
  337. A thirty month clinical experience in natural family planning: some client characteristics and effectiveness in avoiding pregnancies.
  338. A thirty-month clinical experience in natural family planning.
  339. Thoughts on contraception. [Gedanken zur Kontrazeption.]
  340. Three IFRP studies investigate breast-feeding and contraception.
  341. Thrombin inhibitors in women on oral contraceptives.
  342. Thromboembolic complications after taking hormonal contraceptives. [Thromboembolische Komplikationen nach Einnahme hormonaler Kontrazeptiva.]
  343. Thrombosis and oral contraception [letter]
  344. Thrombosis and oral contraception [letter]
  345. Thrombosis and oral contraception. [Letter]
  346. Thrombosis and oral contraception. [Letter]
  347. Thrombosis and oral contraception] [Letter.
  348. Tianjin holds birth control commendation rally.
  349. Tianjin issues decision on family planning.
  350. Toxic-shock studies look at contraceptives as risk factors.
  351. Traditional methods of contraception of the Malays--an exploratory study.
  352. Training community, auxiliary, midwifery, and nursing personnel in family planning: a non-medical perspective.
  353. Training nonphysicians for family planning services in Mexico.
  354. Training village midwives for family planning services delivery in rural Denizli. [Denizli ilinde aile planlamasi hizmet iletiminde koy ebelerinin egitimi.]
  355. Transfer of contraceptive steroids in milk of women using long-acting gestagens.
  356. Transposition of the great vessels in an infant exposed to massive doses of oral contraceptives.
  357. Trends in contraceptive method of use by California family planning clinic clients aged 10-55, 1976-1979.
  358. True and false regarding metabolic risk in contraception. [Le vari et le faux sur le risque metabolique en contraception.]
  359. True and false regarding the genetic risks in contraception. [Le vrai et le faux sur les risques gentiques en contraception.]
  360. True and false regarding the risk of infection in contraception. [Le vrai et le faux sur le risque infectieux en contraception.]
  361. True and false regarding the risks of no contraception. [Le vari et le faux sur les risques d'absence de contraception.]
  362. Twenty years of oral contraception.
  363. Two years experience with intrauterine contraceptive devices (Lippe's loop) in Khartoum area.
  364. Ultrastructural alterations in human endometrium caused by intrauterine contraceptive devices.
  365. Ultrastructure of human spermatozoa in the presence of the spermicide nonoxinol-9 and a vaginal contraceptive containing nonoxinol-9.
  366. The unexpected repression: how family planning discriminates against women in Ghana.
  367. Unmet need for contraception in Pakistan: a review of program targets.
  368. The unmet need for family planning in Latin America and the Caribbean.
  369. Update on oral contraceptives: major studies find ocs safe for most women.
  370. Urine free dopamine in normal primigravid pregnancy and women taking oral contraceptives.
  371. The use of birth control pills in women with medical disorders.
  372. Use of clinic family planning services.
  373. The use of incentives and disincentives in voluntary surgical contraception programs: a review of published literature.
  374. The use of modern family planning in rural Nigeria.
  375. The use of norethisterone oenanthate, an injectable contraceptive, in patients at risk of venous thrombosis.
  376. Use of services for family planning and infertility: United States.
  377. Users of the contraceptive injection in Daveyton.
  378. Using model projects to introduce change into family planning programs.
  379. Vaginal contraception and tensio-actives (author's transl) [Contraception vaginale et tensioactifs.]
  380. Vaginal contraception in perspective.
  381. Vaginal contraception.
  382. Vaginal contraception. Pt. 1 (author's transl) [La contraception vaginale. Pt. 1.]
  383. Value of a means of contraception using microdoses of progesteroids in the immediate post-partum period: a comparative study of three progesteroids, in 150 cases (author's transl) [Interet d'une contraception par progestatifs microdoses dans le post-partum immediat. Etude comparative de trois progestatifs a propos de 150 cas.]
  384. Variations in the incidence of knowledge and use of contraception: a comparative analysis of World Fertility Survey results for twenty developing countries.
  385. Variations in the incidence of knowledge and use of contraception: a comparative analysis of World Fertility Survey results for twenty developing countries.
  386. Vascular effects of hormonal contraception.
  387. Vascular thrombosis and oral contraceptives--a risk correlated study.
  388. Vasectomy: said to be the most effective male contraceptive method, yet it is the least popular.
  389. VDMS Marrakech--household distribution of family planning.
  390. Veins and contraception (author's transl) [Veines et contraception.]
  391. Venous thrombosis of the upper extremity after hormonal contraception. [Tromboza zil horni koncetiny po hormonalni antikoncepci.]
  392. Verbal judgments of Taiwanese family planning field workers about induced abortion.
  393. Vestibular side effects of contraception. [Az anticoncipiensek vestibularis mellekhatasairol.]
  394. Village-based family planning in North Sulawesi.
  395. Visit planning by the rural family planning worker.
  396. Visits to family planning clinics: United States, 1979.

     

  397. Visits to family planning service sites: United States, 1978.
  398. Voluntary efforts in population and family planning.
  399. Voluntary surgical contraception: a descriptive profile of acceptors.
  400. Voluntary surgical contraception: a management study of strategies for promotion and service delivery (Region III experience)
  401. Vulval warts: regression following withdrawal of an oral contraceptive.
  402. The Walnut Creek contraceptive drug study: a prospective study of the side effects of oral contraceptives: volume 3, an interim report, a comparison of disease occurrence leading hospitalization or death in users and nonuse of oral contraceptives.
  403. The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. Vol 3. An interim report--a comparison of disease occurrence leading hospitalization or death in users and nonusers of oral contraceptives.
  404. A comparison between the Multiload Cu 250 and the Lippes Loop intrauterine contraceptive devices. ['n Vergelyking tussen die Multiload Cu 250-endie Lippes Lus-intrauterine kontraseptiewe toestelh.]
  405. Continuation of contraception on Java-Bali: preliminary results from the quarterly acceptor survey.
  406. Contraceptive risk-taking in a population with limited access to abortion.
  407. Contraceptive use and fertility levels in Sao Paulo State, Brazil.
  408. Actinomyces-like organisms in cervical smears from women using intrauterine contraceptive devices.
  409. Assessment of family planning service delivery in Egypt.
  410. Attitudinal and nonattitudinal determinants of contraception: a cross-cultural study.
  411. Bilateral tubal pregnancy in women with intra-uterine contraceptive device in situ (author's transl) [Beidseitige Tubargraviditat bei einer Frau mit liegendem Intrauterinpessar.]
  412. Black couples and birth control: knowledge, attitudes, and reported practices.
  413. Characteristics of contraceptive acceptors in rural Zaire.
  414. Characteristics of successful distributors in the community-based distribution of contraceptives in Guatemala.
  415. Cholangiocarcinoma and oral contraceptives.
  416. Clearance of bacteriuria on discontinuing oral contraception [letter]
  417. Clearance of bacteriuria on discontinuing oral contraception [letter]
  418. Clearance of bacteriuria on discontinuing oral contraception [letter]
  419. Contraception in the adolescent. [Letter]
  420. Contraceptive distribution in Bangladesh: some lessons learned.
  421. Contraceptive efficacy: the significance of method and motivation.
  422. Contraceptive habits in women between thirty and fifty years of age. A comparison of two periods, 1967-69 and 1972-74.
  423. Contraceptive practice among abortion seeking women and controls. [Abstract]
  424. Desire for children and family planning in Algeria: approach to reproduction in Arab countries (author's transl) [Kinderwunsch und familienplanung in Algeria: ein beitrag sum reprodukstionsverhalten in arabischen landern.]
  425. Do family planning field workers approve of induced abortion?
  426. Effects of hormonal contraceptives on parameters of lipid metabolism (author's transl) [Der Einfluss hormonaler Kontrazeptiva auf Parameter des Fettstoffwechsels.]
  427. The family planning program of the Secretaria de Salubridad y Asistencia in the border states. [El programa de planificacion familiar de la Secretaria de Salubridad y Asistencia en los estados fronterizos.]
  428. Fertility control in the United States before the contraceptive revolution.
  429. Free norethisterone as reflected by norethisterone concentrations in the saliva during oral contraceptive use. [Abstract]
  430. Household distribution of contraceptives in rural Egypt.
  431. Impact of the national family planning program on fertility in rural Korea: a multivariate areal analysis.
  432. Interaction between oral contraceptives and other drugs.
  433. Intrauterine contraception and tubal pathology.
  434. IUD and family planning in Indonesia: role of multiload copper IUD. [Abstract]
  435. Kenya WFS: fertility high; contraceptive practice low; most women say they want large families.
  436. Liver tumours and oral contraceptives [letter]
  437. Local effects of intrauterine contraceptives placed within the peritoneal cavities of rabbits.
  438. The Matlab Family Planning-Health Services Project.
  439. Medicamentous enzyme induction and hormonal contraception. First communication: effects of anti-epileptics on hormonal contraception of epileptics. (Author's transl) [Medikamentose enzyminduktion und hormonale kontrazeption 1. Mitteilung: einfluss von antiepileptika auf die hormonale kontrazeption bei epileptikerinnen.]
  440. Medicamentous enzyme induction and hormonal contraception. Second communication: effects of phenobarbital and phenylbutazone on hormonal contraception. (Author's transl) [Medikamentose enzyminduction und hormonale kontrazeption 2. Mittellung: einfluss von phenobarbital und phenylbutazon aut die hormonale kontrazeption.]
  441. Menarche of young girls and tolerance of hormonal contraceptives results of a field study of 33,000 cases (author's transl) [Menarche und vertraglichkeit hormonaler kontrazeption bei ingendlichen: ergebnisse aus einer feldstudie an 33,000 frauen.]
  442. Metabolic effects of different types of oral contraception in insulin-dependent and latent diabetes. [Abstract]
  443. The no-birth bonus scheme: the use of savings accounts for family planning in South India.
  444. Norplant: reversible implant contraception.
  445. Oral contraceptives and post-molar trophoblastic tumours. [Letter]
  446. The purchase of contraceptives by college students.
  447. Repeat abortion and self-reported contraceptive behavior. [letter]
  448. Role of non-physician health professionals in family planning in the United States. [Abstract]
  449. Serum bile acid levels during oral contraceptive treatment with ethinyl estradiol and norgestrel. [Abstract]
  450. Service availability and the unmet need for contraceptive services in Sao Paulo State, Brazil.
  451. Sex education and contraceptive practice amongst abortion patients.
  452. Sexuality and contraception: a study of 548 female university students. [Sessualita e contraceccizione: indagine su 548 stedentesse universitairie.]
  453. Staphylococcal septicaemia after insertion of an intrauterine contraceptive device. [Letter]
  454. Support for family planning.
  455. A survey of attitudes towards permanent contraceptive methods.
  456. Telling parents: clinic policies and adolescents' use of family planning and abortion services.
  457. Trends in contraceptive use at one university: 1974-1978.
  458. Tubal clip-sterilization or reversible contraception? [Abstract]
  459. Two methods of natural family planning [letter]
  460. User preferences for contraceptive methods in India, Korea, the Philippines, and Turkey.
  461. Traditional midwives and family planning./Parteiras tradicionais e planejamento familiar./Les sages-femmes traditionnelles et le planning familial./Las parteras tradicionales y la planificacion familiar.
  462. 10 views on the Catholic Church's stand on birth control.
  463. 1979 Korea Contraceptive Prevalence Survey report.
  464. 1979 Philippine National Acceptor Survey (NAS). Contraceptive effectiveness of methods offered by the Philippine Family Planning Program.
  465. 1980: a difficult time for contraceptive research.
  466. A.I.D. funded operations research in family planning delivery: an interim overview.
  467. Abortion and birth control. [Avortement et regulation des naissances.]
  468. Abortion and contraceptives. 3rd ed. [Aborto y contraceptivos. Tercera edicion.]
  469. Abortion and family planning: law and the moral issue.
  470. Abortion or contraception. [Aborto o anticoncepcion.]
  471. Abortion, contraception and motherhood in post-war Japan and the United States.
  472. The communication process with emphasis on communication skills and techniques in family planning.
  473. Communications for social marketing: a methodology for developing communication appeals for family planning programs.
  474. Community sex education for the family planning health educator.
  475. Comparative evaluation of two methods of natural family planning in Colombia.
  476. A comparative study of standard-dose oral contraceptives in rural Bangladesh.
  477. Comparative study of the effect of oral contraceptives containing 50 mcg of estrogen and those containing 20 mcg of estrogen on adrenal cortical function.
  478. Comparison of a paper pill with a conventional oral contraceptive tablet.
  479. A comparison of birth control pill user data from two national surveys.
  480. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
  481. Comparison of results of Contraceptive Prevalence Surveys in five countries.
  482. A comparison of the factors influencing husband and wife decisions about contraception.
  483. A comparison of three approaches to providing contraceptive counseling.
  484. A comparison of younger and older adolescent females attending birth control clinics.
  485. The concept of demand for family planning and its measurement.
  486. Conception and contraception: a guide to family planning.
  487. Conn adenoma after prolonged use of oral contraceptives. [Adenomes de Conn apres prise prolongee d'estroprogestatifs.]
  488. Considerations about 548 insertions of IUD at the Family Planning Center of the University of Rome (authors transl) [Considerazioni su 548 inserzioni di IUD presso il centro de planificazione familiare dell'universita di Roma.]
  489. Considerations about 548 insertions of IUDs at the Family Planning Center of the University of Rome (author's transl) [Considerazioni su 548 inserzioni di IUD presso il centro di pianificazione familiare dell' Universita di Roma.]
  490. Consumer perspective in family planning, Mojokerto, East-Java.
  491. Contraception after abortion (Author's transl) [La contraception apres l'interruption volontaire de grossesse.]
  492. Contraception and adolescent pregnancy.
  493. Contraception and infant health. [Anticoncepcao e saude infantil.]
  494. Contraception and its complications.
  495. Contraception and liberal medical acts: the results of a national enquiry carried out by INSERM 1974-1975 (author's transl) [Contraception et activite medicale liberale: resultats de l'enquete nationale INSERM 1974-1975.]
  496. Contraception and sterilization: a brief history.
  497. Contraception and sterilization: a modern dilemma.
  498. Contraception and the attitudes of married Polish women towards abortion: a research note.
  499. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
  500. Contraception and the lactating women.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.